- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: DNA topoisomerase.
Displaying page 1 of 1.
EudraCT Number: 2007-007849-13 | Sponsor Protocol Number: GCIG/JGOG 3017 | Start Date*: 2009-03-27 | |||||||||||
Sponsor Name:Kitasato institute clinical trial coordinating center | |||||||||||||
Full Title: Randomised Phase III Trial of Paclitaxel plus Carboplatin (TC) Therapy versus Irinotecan plus Cisplatin (CPT-P) Therapy as a First Line Chemotherapy for Clear Cell Carcinoma of the Ovary | |||||||||||||
Medical condition: Clear Cell Carcinoma of the Ovary | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Ongoing) IT (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002169-16 | Sponsor Protocol Number: ERASE-CRC | Start Date*: 2022-06-10 | ||||||||||||||||
Sponsor Name:Fondazione GONO | ||||||||||||||||||
Full Title: EXPLOITING CIRCULATING TUMOUR DNA TO INTENSIFY THE POST-OPERATIVE TREATMENT OF STAGE III AND HIGH-RISK STAGE II RESECTED COLON CANCER PATIENTS WITH ADJUVANT FOLFOXIRI AND/OR POST-ADJUVANT TRIFLURID... | ||||||||||||||||||
Medical condition: STAGE III AND HIGH-RISK STAGE II RESECTED COLON CANCER PATIENTS. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001206-29 | Sponsor Protocol Number: ShorTrip | Start Date*: 2021-07-22 | |||||||||||
Sponsor Name:Fondazione GONO | |||||||||||||
Full Title: ShorTrip study - Phase II study of Short-course radiotherapy followed by consolidation chemotherapy with the Triplet FOLFOXIRI as total neoadjuvant therapy for locally advanced rectal cancer. | |||||||||||||
Medical condition: Locally advanced rectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001501-24 | Sponsor Protocol Number: AVETRIC | Start Date*: 2020-02-13 | |||||||||||
Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST | |||||||||||||
Full Title: PHASE II STUDY OF AVELUMAB AND CETUXIMAB AND MODIFIED FOLFOXIRI AS INITIAL THERAPY FOR RAS WILD-TYPE UNRESECTABLE METASTATIC COLORECTAL CANCER PATIENTS | |||||||||||||
Medical condition: Metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000601-27 | Sponsor Protocol Number: MERCURY | Start Date*: 2022-09-27 | |||||||||||
Sponsor Name:Fondazione GONO | |||||||||||||
Full Title: Window-of-opportunity study of chemo-immunotherapy in patients with resectable Merkel Cell Carcinoma prior to surgery: the MERCURY trial | |||||||||||||
Medical condition: The disease under clinical investigation is represented by resectable Merkel Cell Carcinoma (MCC), stage IIA-III (according to the AJCC staging system 8th edition). The study will include patients ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001491-29 | Sponsor Protocol Number: Prodige52–UCGI29 | Start Date*: 2016-10-13 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: A Phase III, Randomised, international trial comparing mFOLFIRINOX triplet chemotherapy to mFOLFOX for high-risk stage III colon cancer in adjuvant setting | |||||||||||||
Medical condition: High-risk stage III colon cancer in adjuvant setting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007799-13 | Sponsor Protocol Number: 48226787 | Start Date*: 2009-03-05 | |||||||||||
Sponsor Name:Vejle Sygehus | |||||||||||||
Full Title: Panitumumab (Vectibix®) og liposomal doxorubicin (Caelyx®) til platinresistent epithelial ovariecancer uden KRAS mutationer | |||||||||||||
Medical condition: Platinresistent epithelial ovariecancer uden KRAS mutationer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) SE (Ongoing) AT (Completed) BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003832-30 | Sponsor Protocol Number: 11-PIR-11 | Start Date*: 2012-06-21 | |||||||||||||||||||||
Sponsor Name:Nektar Therapeutics | |||||||||||||||||||||||
Full Title: The BEACON Study (BrEAst Cancer Outcomes with NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physician’s Choice (TPC) in Patients with Locally Recurr... | |||||||||||||||||||||||
Medical condition: Locally Recurrent Breast Cancer, Metastatic Breast Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) GB (Completed) DE (Completed) ES (Completed) NL (Completed) IT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-023584-17 | Sponsor Protocol Number: RAS-AZIC | Start Date*: 2012-08-31 | |||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||
Full Title: Response-Adapted Sequential Azacitidine And Chemotherapy in Patients > 60 Years Old With Newly Diagnosed AML Eligible for Chemotherapy and allogeneic hematopoietic cell transplantation: A Multicent... | |||||||||||||
Medical condition: acute myeloid leukeamia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
